Browsing Blizard Institute by Subject "Kaplan-Meier Estimate"
Now showing items 1-2 of 2
-
Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.
(2017-09-12)OBJECTIVE: To evaluate 5-year efficacy and safety of alemtuzumab in patients with active relapsing-remitting multiple sclerosis and inadequate response to prior therapy. METHODS: In the 2-year Comparison of Alemtuzumab and ... -
Trends in missed presentations and late HIV diagnosis in a UK teaching hospital: a retrospective comparative cohort study.
(2012-03-28)BACKGROUND: Late diagnosis is an important cause of HIV-related morbidity, mortality and healthcare costs in the UK and undiagnosed infection limits efforts to reduce transmission. National guidelines provide recommendations ...